Skip to main content

Table 4 Characteristics of the farms included in the study

From: Piglet nasal microbiota at weaning may influence the development of Glässer’s disease during the rearing period

Farm

Health status

Location

Sow farm size

Production system

Antibiotic treatment

MT

Glässer’s disease (GD)

Spain

3300

Multi-site

Pen + Strep

MC

Glässer’s disease (GD)

Spain

480

Farrow to finish

Ceft

RC

Glässer’s disease (GD)

Spain

1400

Multi-site

Ceft

EJ

Glässer’s disease (GD)

Spain

2000

Multi-site

Enro

VL

Control (C)

Spain

700

Farrow to finish

Tul + Ceft

PT

Control (C)

Spain

1000

Multi-site

NA

GM

Control (C)

Spain

1200

Multi-site

Amox

GW

Control (C)

UK

300

Farrow to finish

Amox

KD

Control (C)

UK

750

Multi-site

none

LG

Control (C)

UK

500

Farrow to finish

none

  1. Pen Penicillin, Strep Streptomycin, Ceft Ceftiofur, Enro Enrofloxacin, Tul Tulathromycin, Amox Amoxicillin, NA Not available